Application Value of Coronary CTA in Predicting Adverse Cardiovascular Events in Patients with Coronary Heart Disease Combined with Atrial Septal Defect
Objective:To investigate the application value of coronary CT angiography(CTA)in predicting adverse cardiovascular events(MACE)in patients with coronary atherosclerotic heart disease combined with atrial septal defect.Methods:The data of 60 patients with coronary heart disease combined with atrial septal defect admitted to Jining Third People's Hospital from January 2022 to April 2024 were retrospectively analyzed.Patients were grouped according to whether MACE occurred during hospitalization admission,the results of coronary CTA examination were compared between the two groups,and the influencing factors of MACE occurrence in patients with coronary heart disease complicated with atrial septal defect were analyzed,and the application value of coronary CTA examination in predicting the occurrence of MACE in patients complicated with atrial septal defect was analyzed.Results:MACE occurred in 31.67%(19/60)and did not occur in 68.33%(41/60)within 1 year after admission.The incidence of vulnerable plaque in MACE group was 63.16%,which was higher than 26.83%in non-MACE group.Non-calcified plaque,calcified plaque and total plaque volume,degree of coronary artery stenosis,and lesion length were all higher than those in non-MACE group(P＜0.05).The plaque properties of vulnerable plaque,non-calcified plaque volume,calcified plaque volume and total plaque volume,greater degree of coronary artery stenosis,and longer lesion length were associated with the occurrence of MACE in patients with coronary heart disease combined with atrial septal defect(P＜0.05).The area under the curve(AUC)of plaque properties,non-calcified plaque volume,calcified plaque volume and total plaque volume,coronary artery stenosis degree,and lesion length were 0.682,0.926,0.686,0.946,0.829,0.851,and 0.995,respectively,and the AUC of combined detection was the highest.Conclusion:CTA examination has a high application value in predicting the occurrence of MACE in patients with coronary heart disease complicated with atrial septal defect
万方数据
维普
